Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,544 JPY | -1.15% | +1.28% | -8.39% |
02/05 | Poseida Therapeutics to Receive Up to $600 Million in Cancer Gene Therapy Research, Development Deal With Xyphos | MT |
01/05 | Malin Corp investee signs agreement with Astellas Pharma | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.39% | 18.14B | |
+33.06% | 700B | |
-4.58% | 358B | |
+20.15% | 330B | |
+4.71% | 287B | |
+15.72% | 236B | |
+6.63% | 202B | |
-9.24% | 197B | |
+4.44% | 161B | |
-3.46% | 157B |
- Stock Market
- Equities
- 4503 Stock
- News Astellas Pharma Inc.
- China Approves Sale of Humanwell Healthcare Unit's Prostate Cancer Treatment